Health Care & Life Sciences » Healthcare Provision | Shin Nippon Biomedical Laboratories Ltd.

Shin Nippon Biomedical Laboratories Ltd.

Shin Nippon Biomedical Laboratories Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY46.85
Market Cap
JPY30.97 B
Shares Outstanding
41.63 M
Public Float
19.04 M

Profile

Address
St. Luke's Tower, 12/F
Tokyo Tokyo 104
Japan
Employees -
Website http://www.snbl.co.jp
Updated 07/08/2019
Shin Nippon Biomedical Laboratories, Ltd. is a contract research organization providing drug development services including safety research, clinical pharmacology, and clinical trials. Its operations are carried out through the following segments: Preclinical Business, Clinical Business, Translational Research Business, Medipolis Business, and Others. The Preclinical Business segment verifies the efficacy and safety of new drugs using experimental animals and bacterial cells.

Financials

View All

Ryoichi Nagata
Chairman, President & Chief Executive Officer
Ken Takanashi
COO, Representative Director & Vice President